Astex Awarded The Sunday Times Microsoft Tech Track 100 Research and Development Award 2004
02. Dezember 2004 06:57 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Dec. 02, 2004 (PRIMEZONE) --
* Astex Technology, the fragment-based drug discovery and
development company, received the Research and Development Award
...
Astex achieves drug discovery collaboration success with Schering AG
25. Oktober 2004 02:34 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 25, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has completed a significant goal in its multi-target...
Astex strengthens management team -- Martin Buckland joins as Senior Vice President, Business Development
11. Oktober 2004 03:34 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 11, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Martin Buckland as Senior Vice...
Astex ranked top biotech company for the second year running in The Sunday Times Microsoft Tech Track 100
05. Oktober 2004 09:39 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Oct. 5, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, is again ranked as the fastest growing biotechnology company in the Sunday Times...
Astex Reveals Structure of Key Drug Metabolizing Enzyme -- Cytochrome P450 3A4 -- in Science
16. Juli 2004 02:40 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, July 16, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that its scientists had published the...
Astex Extends Research Collaboration with Aventis
08. Juni 2004 02:45 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., June 8, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has extended its existing structural biology research...
Astex Achieves Second Milestone in Alzheimer's Drug Discovery Collaboration with AstraZeneca
19. April 2004 02:15 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., April 19, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that it has received the second milestone payment from AstraZeneca as part...
Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology Announce Major Cancer Drug Discovery Collaboration
22. März 2004 03:33 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 22, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research...
Astex Announces Drug Discovery Alliance with Boehringer Ingelheim
09. März 2004 02:10 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 9, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced a three year, multi-target-based, alliance with Boehringer Ingelheim for the...
Astex Strengthens Oncology Expertise -- Director of Oncology Joins Management Team
12. November 2003 04:12 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Nov. 12, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced the appointment of Dr John Lyons as Director of Oncology. Dr Lyons will...